Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person4
iSpecimen Inc.
Company
INNOSPEC INC.
Company
SPECIFICITY, INC.
Company
PRECIGEN, INC.
Company
Primary record11
iSpecimen Inc. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. On November 2, 2026 (the “Closing Date”), iSpecimen Inc. (the “Company”) and Foldlab AI Ltd., a company organized under the laws of British Columbia (“Foldlab” or th
iSpecimen Inc. filed 8-K
Item 5.07 Submission of Matters to a Vote of Security Holders. As previously reported, on October 9, 2026, iSpecimen Inc. (the “Company”) convened a special meeting of stockholders (the “Special Meeting”), at which the C
iSpecimen Inc. filed 8-K
Item 5.07 Submission of Matters to a Vote of Security Holders. On October 9, 2026, iSpecimen Inc. (the Company ) held a special meeting of stockholders (the Special Meeting ). As of the close of business on August 12, 20
iSpecimen Inc. filed DEF 14A
SEC form DEF 14A filed by iSpecimen Inc. (CIK 1558569) on 2026-09-14.
iSpecimen Inc. filed 8-K
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 8, 2026, iSpecimen Inc. (the “Company”) received a letter dated September 8, 2026 (the “Deficie
iSpecimen Inc. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. On September 4, 2026, iSpecimen Inc., a Delaware corporation (the “Company”), entered into an Asset Purchase Agreement (the “Agreement”) with Foldlab AI Ltd., a comp
iSpecimen Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers. Departure of Chief Executive Officer On August 26, 2026, Katharyn Field informed the Board of Directors (the
iSpecimen Inc. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. On August 12, 2026, iSpecimen Inc. (the “Company”) entered into a Consulting Agreement (the “Consulting Agreement”) with IR Agency LLC (the “Consultant”), pursuant t
iSpecimen Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On August 6, 2026, iSpecimen Inc. (the “Company”) entered into a Settlement Agreement and Mutual Release (the “Settlement Agreement”) with WestPark Capital, Inc. (“We
iSpecimen Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On August 5, 2026, iSpecimen Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with E.F. Hutton & Co. (the “Placement
iSpecimen Inc. filed 424B4
SEC form 424B4 filed by iSpecimen Inc. (CIK 1558569) on 2026-08-07.